Key Takeaways
- U.S. equity markets showed resilience, with the S&P 500 and Nasdaq Composite posting slight gains by Friday's close, while Chinese markets, notably the NASDAQ Golden Dragon China Index, experienced a significant 2.6% decline, marking its steepest fall since August 27th.
- Johnson & Johnson (JNJ) is reportedly in advanced discussions to acquire Protagonist Therapeutics (PTGX), according to the Wall Street Journal, a development that saw Protagonist shares surge.
- Geopolitical tensions escalated as China expanded its rare earth export controls, prompting former President Trump to comment on Beijing's "hostile" actions, while Switzerland aims to finalize a free trade agreement with China by early 2026.
- European leaders welcomed a Middle East ceasefire agreement and planned hostage release, with former President Trump receiving thanks for his diplomatic efforts, even as French political negotiations over pension reform remain contentious, with the Ecologist Party expressing dissatisfaction.
Global Markets Present Mixed Performance Amid Geopolitical Headwinds
Global equity markets displayed a divergent performance on Friday, October 10, 2025. While U.S. indices recovered to post slight gains, with the Dow Jones Industrial Average advancing 0.3%, the Nasdaq Composite and S&P 500 both rising 0.2% in recent trading, Asian markets faced significant downward pressure. This recovery in U.S. markets followed earlier declines during the week, with the S&P 500 having slipped 0.3% on Thursday.
Conversely, Chinese stocks experienced a notable downturn, with the NASDAQ Golden Dragon China Index falling 2.6%, its largest single-day drop since August 27th. The Hong Kong Hang Seng index also shed 1.8%, and the Shanghai Composite slipped nearly 1%, reflecting broader concerns in the region.
Johnson & Johnson Pursues Protagonist Therapeutics in Biotech M&A
Pharmaceutical giant Johnson & Johnson (JNJ) is reportedly in talks to acquire Protagonist Therapeutics (PTGX), as disclosed by the Wall Street Journal. The news triggered a significant surge in Protagonist's shares, which spiked 10% before being temporarily halted for volatility. The two companies already have an existing partnership, codeveloping a treatment for ulcerative colitis. A potential acquisition would further bolster J&J's portfolio, possibly adding experimental therapies like rusfertide, which has shown promise in a rare blood cancer.
Rising Geopolitical Tensions and Trade Dynamics
Geopolitical developments continue to shape the global economic landscape. Former President Trump took to Truth Social to express concerns over China's actions, stating that "very strange things are happening in China!" and highlighting their alleged "hostile" stance on imposing export controls on rare earths. China has indeed broadened its restrictions on rare earth elements, adding five more to its control list and implementing stricter rules, particularly targeting users in the semiconductor industry. These measures, which take effect in November and December 2025, are seen as a strategic move by Beijing to leverage its dominance in the rare earth supply chain ahead of a scheduled meeting between President Trump and Chinese President Xi Jinping.
Meanwhile, Switzerland's Foreign Minister expressed optimism for a free trade agreement with China by the beginning of 2026, aiming to upgrade their existing 2013 FTA. In Europe, the EU is reportedly planning a new proposal to implement a trade deal with the U.S., seeking to bypass Washington's demands for the bloc to dismantle certain regulations. EU officials view the U.S. requests for concessions as "maximalist".
European Leaders Welcome Middle East Ceasefire Amid French Political Strife
In a significant diplomatic development, leaders from Britain, France, and Germany issued a joint statement welcoming a Middle East ceasefire agreement and the planned release of hostages. Former President Trump was thanked for his leadership in brokering the deal. Russian President Vladimir Putin also praised Trump's "real efforts" towards peace, particularly regarding the Middle East ceasefire.
Domestically, French politics remain turbulent, with Marine Tondelier of the Ecologist Party stating that while President Macron was prepared to delay the application of pension reform, it was "not enough". Following a meeting with Macron, Tondelier indicated that the next Prime Minister would not be from their party, highlighting ongoing difficulties in forming a consensus government and navigating the contentious pension reform. The political wrangling comes as France faces warnings from rating agencies regarding its sovereign credit score.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.